796 - HIV transmission clusters among people who inject drugs in North Carolina, 2010 to 2021

Presenting Author(s)

• 

  Theppharit Panichsillapakit, MD

  ID fellow
  UNC-CH
  Chapel Hill, NC, United States

  Disclosure: Disclosure(s): No financial relationships to disclose

Co-Author(s)

• KE

  Kimberly Enders, PhD

  niversity of North Carolina at Chapel Hill
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• AG

  Annalea C. Greifinger, MPH

  Data Manager
  UNC-CH
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Shuntai Zhou, MD

  Assistant Professor
  UNC-Chapel Hill
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• SF

  Simon Frost, MA DPhil

  Microsoft Research
  Redmond, Washington, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• RS

  Ronald Swanstrom, PhD

  UNC-CH
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Joseph J. Eron, MD

  Professor
  University of North Carolina at Chapel Hill School of Medicine
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): GSK: Advisor/Consultant (); Merck: Advisor/Consultant ()
• VM

  Victoria Mobley, MD, MPH

  North Carolina Department of Health and Human Services
  Raleigh, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• ES

  Erika Samoff, PhD MPH

  HIV Surveillance Manager
  North Carolina Department of Health and Human Services
  Raleigh, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  Ann Dennis, MD

  Assistant Professor
  UNC-CH
  Chapel Hill, North Carolina, United States

  Disclosure: Disclosure(s): No financial relationships to disclose